Jennifer Taubert, EVP and Worldwide Chairman of Innovative Medicine, to retire Sept 1, 2026

JOHNSON & JOHNSON

Jennifer Taubert retiring as EVP, Worldwide Chairman of Innovative Medicine and member of Executive Committee.
Retirement effective September 1, 2026.
No successor has been named at this time.
Announcement made on August 4, 2026.

item 5.02 item 9.01

JOHNSON & JOHNSON filing history →

Source: SEC EDGAR

accession 0000200406-26-000167

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.